Using this assay, we show for the first time that VAMP-2, Ng and SNAP-25 have similar biphasic profiles over the course of the AD continuum compared to controls, showing changes that precede those of other CSF markers of tau-mediated neurodegeneration. This evidence concerns the gene MAPT and Alzheimer disease.